Selena Gomez underwent a life-saving kidney transplant due to lupus nephritis Read ahead to know what lupus nephritis is its ...

Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro’s superiority over standard therapy alone1,2Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

DelveInsight's Lupus Nephritis Market Insights report includes a comprehensive understanding of current treatment practices, lupus nephritis emerging drugs, market share of individual therapies, and ...

Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care ...

Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro's superiority over standard therapy alone1,2 Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

Investigators employed the Accelerating Medicines Partnership to identify noninvasive biomarkers of lupus nephritis pathology and treatment response.

Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

Notably, 2 deaths occurred in the iscalimab group, 1 due to urosepsis and another associated with macrophage-activation syndrome. Opportunistic infections, including tuberculosis and herpes zoster, ...

Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising ...

The ORIGIN Phase 3 trial met the primary endpoint with a statistically significant and clinically meaningful reduction in proteinuria at week 36, in the prespecified interim analysis. Across the ...